The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
The bacterial chaperone CsgC inhibits functional amyloid CsgA formation by promoting the intrinsically disordered pre-nuclear state
Open accessPreprint — published as 10.1016/j.jbc.2025.110217 · Paper page
Abstract
E. coli assembles a functional amyloid called curli during biofilm formation. The major curlin subunit is the CsgA protein, which adopts a beta-sheet rich fold upon fibrillization. The chaperone-like protein CsgC inhibits CsgA amyloid formation. CsgA undergoes a 3-stage aggregation process: an initial lag phase where beta-rich nuclei form, an exponential elongation phase, and a plateau phase. It is currently not known if CsgC inhibits amyloid formation by inhibiting formation of a pre-fibril nucleus, or if CsgC inhibits a later stage of amyloid formation by blocking monomer addition. Here, CsgC homologs from C. youngae , C. davisae , and H. alvei were purified and characterized for their ability to interrogate CsgA amyloid formation. Each of the CsgC homologs prolonged the lag phase of E. coli CsgA amyloid formation similar to E. coli CsgC. Additionally, we found E. coli CsgC interacted transiently and weakly with a monomeric, pre-nucleus species of CsgA which delayed amyloid formation. A transient CsgC-CsgA heterodimer was observed using ion mobility-mass spectrometry. When CsgC was added to actively polymerizing CsgA, exponential growth commonly associated with nucleation-dependent amyloid formation was lost. Adding preformed CsgA seeds did not rescue exponential growth, indicating that CsgC also has inhibitory activity during fibril elongation. Indeed, CsgC interacted strongly with CsgA fibers, suggesting the interaction between CsgC and CsgA fibers can slow new fiber growth. CsgC displays unique inhibitory activity at multiple stages of amyloid formation. CsgC acts as an energy-independent chaperone that transiently interacts with prefibrillar CsgA and an amyloid fiber.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Highly accurate protein structure prediction with AlphaFold
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03819-2 · Cited by 43,764
Flagged first, then by citations
Research works printed but not linked: 53
- 10.1146/annurev-biochem-061516-045115 · DOI · Paper page
- 10.1146/annurev.biochem.75.101304.123901 · DOI
- 2002, Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases, Nature, 2002, 6880
- 2007, Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer’s amyloid β-peptide, Nature Reviews Molecular Cell Biology, 2007, 2
- 10.3390/microorganisms8121951 · DOI
- 10.1126/science.1067484 · DOI
- 10.4161/pri.4.4.13676 · DOI
- 10.1016/j.jmb.2018.07.007 · DOI
- 10.1111/j.1365-2958.2011.07706.x · DOI
- 10.1073/pnas.0703310104 · DOI
- 10.1073/pnas.0812143106 · DOI
- 10.1016/j.molcel.2014.12.025 · DOI
- 10.1016/j.str.2011.05.015 · DOI
- 10.1038/srep24656 · DOI
- 10.1016/S0959-440X(99)00049-4 · DOI
- 10.1016/j.tim.2015.07.010 · DOI
- 10.1016/j.molcel.2014.12.025 · DOI
- 10.1039/D1SC05790A · DOI
- 10.1074/jbc.M112.383737 · DOI
- 10.1107/S0907444910042022 · DOI
- 2018, Bacterial amyloids. in Methods in Molecular Biology, Humana Press Inc, 1779, 267
- 10.3389/fmicb.2020.00944 · DOI
- 10.1371/journal.pone.0025157 · DOI
- 10.1039/C4CP05563B · DOI
- 10.1371/journal.pone.0051274 · DOI
- 2016, Molecular mechanisms of protein aggregation from global fitting of kinetic models, Nature Protocols, 2016, 2
- 10.1371/JOURNAL.PBIO.0020321 · DOI
- 10.1016/j.abb.2007.05.015 · DOI
- 10.1021/bi200967c · DOI
- 10.1074/jbc.M609228200 · DOI
- 10.1021/cr068107d · DOI
- 10.1021/ACS.CHEMREV.1C00212/ASSET/IMAGES/LARGE/CR1C00212_0030.JPEG · DOI
- 10.1021/ac504720m · DOI
- 10.1002/pmic.201800060 · DOI · Paper page
- 10.1110/ps.051762406 · DOI
- 10.1073/pnas.1220326110 · DOI
- 10.1039/c3cp50721a · DOI
- 2011, Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation, Nature, 2011, 7354
- 10.1021/bi8005797 · DOI
- 10.3390/IJMS19092677 · DOI
- 10.1038/nchembio.2413 · DOI
- Gharibyan, A. L. , Jayaweera, S. W. , Lehmann, M. , Anan, I. , and Olofsson, A . (2022) Endogenous Human Proteins Interfering with Amyloid Formation. Biomolecules 2022, Vol. 12, Page 446. 12, 446 · DOI
- 2016, Kinetic analysis reveals the diversity of microscopic mechanisms through which molecular chaperones suppress amyloid formation, Nature Communications, 2016, 1
- 10.1016/j.tim.2015.07.010 · DOI
- 10.1128/MBIO.02279-18/SUPPL_FILE/MBIO.02279-18-S0003.PDF · DOI
- 10.1110/ps.073164107 · DOI
- 10.1002/pro.5178 · DOI
- 10.1126/SCIADV.ABN6831 · DOI
- 10.1016/B978-0-443-21809-5.00006-5 · DOI
- 10.1073/pnas.181342398 · DOI
- 10.1093/nar/gki198 · DOI
- 10.1093/bioinformatics/9.6.745 · DOI
- 10.1016/0022-2836(80)90283-1 · DOI
Metadata
- Authors
- Balistreri, A., Kolli, D., Jayaweera, S. W., Lundahl, D., Han, Y., Kalcec, L., Goetzler, E., Alessio, R., Ruotolo, B., Olofsson, A., & Chapman, M. R.
- Affiliations
- University of Michigan (US)
- Umeå University (SE)
- Corresponding author
- Chapman, Matthew R.
- ORCID
- Venue
- Journal of Biological Chemistry
- Publisher
- openRxiv
- Published
- 2025-03-21
- Volume
- 301
- Issue
- 6
- Pages
- 110217-110217
- ISSN
- 0021-9258 (ISSN-L)
- PMC
- PMC12205649
- OpenAlex
- W4410200313
- Cited by
- 10
- References
- 1
- Citations by year
- 2026: 9 · 2025: 1
- FWCI
- 3.01
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion)
- Diva portal (Dalarna University Library) (submittedVersion, other-oa)
- Funders
- Foundation for the National Institutes of Health (R01 GM095832, T32 AI007528, R01GM118651, R21 AI137535)
- National Institutes of Health (AI007528, GM118651)
- National Institute of General Medical Sciences (R01GM095832, R01GM118651)
- National Institute of Allergy and Infectious Diseases (R21AI137535, T32AI007528)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Structural Characterization
- Keywords
- CsgA, curli, functional amyloids, amyloid formation inhibition, molecular chaperones, nucleation, fibril elongation, Escherichia coli biofilm, heterodimer, Citrobacter youngae, Cedecea davisae, Hafnia alvei
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review